期刊文献+

消渴安糖方对2型糖尿病患者胰岛素受体的影响 被引量:6

Effect of Xiaoke Antang Formula on Insulin Receptors in Patients with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的:研究消渴安糖方对2型糖尿病患者血红细胞胰岛素受体活性和数量的影响,探讨消渴安糖方的降糖机制。方法:将40例初发2型糖尿病患者随机分为治疗组(消渴安糖方联合胰岛素皮下注射治疗组)和对照组(胰岛素皮下注射治疗组),均用药2周,观察两组临床疗效,分别观察治疗指标:糖化血红蛋白(HbA1c)、空腹胰岛素(FIns)、胰岛素功能指数(HOMA-IS)、胰岛素抵抗指数(HOMA-IR)以及红细胞胰岛素受体k1,r1,r2,k2值的变化情况,进行对比分析。结果:两组疗效比较无显著性差异(P>0.05),但治疗组在改善患者FINS、HOMA-IR、HOMA-IS以及胰岛素受体数量方面均优于对照组(P<0.05或P<0.01)。结论:消渴安糖方联合胰岛素治疗不仅可以降血糖,改善糖尿病患者临床症状,而且可以通过改善胰岛素受体的活性和数量来减轻糖尿病患者的胰岛素抵抗程度。 Objective: To study the effect of Xiaoke A ntang formula on activity and quantity of insulin receptors of erythrocytes in patients with type 2 diabetes mellitus and to investigate the hypoglycemic mechanism of Xiaoke A ntang formula. Methods: Forty in-patients with new-onset Type 2 diabetes mellitus were randomized to receive subcutaneous injection of insulin alone (control group) or in combination with Xiaoke Antang formula (treatment group) for 2 weeks. Changes in efficacy measures, including HbAIc, Fins, HOMA-IS, HOMA-IR and values of k1, r1,r2 and k2 (insulin receptors of erythrocytes) were observed and comparatively analyzed. Results: There was no significant difference in efficacy between the two groups (P 〉 0.05 ). However, the improvement of Fins, HOMA- IR, HOMA-IS and the quantity of insulin receptors in the treatment group were greater compared with the control group (P 〈0.05 or P〈0.01 ). Conclusions: Treatment with Xiaoke Antang formula plus subcutaneous injection of insulin may improve the clinical symptoms of diabetes by decreasing blood glucose and reduce insulin resistance by improving the activity and quantity of insulin receptors in patients with diabetes.
机构地区 广西中医学院 不详
出处 《广西中医药》 2009年第1期8-10,共3页 Guangxi Journal of Traditional Chinese Medicine
基金 广西研究生教育创新计划资助项目(项目编号:2008106001005M21)
关键词 2型糖尿病 胰岛素抵抗 胰岛素受体 中西医结合疗法 Type 2 Diabetes Mellitus Insulin Resistance Insulin Receptor Combined Therapy of Traditional Chinese and Western Medicine
  • 相关文献

参考文献4

  • 1Matthews DR,Hosker JP, Rudenski AS, et al.Homeostasis model assessment:insulin resistance and betacell function from fasting plasma glucose and insulin concen-rations in man [J]. D iabetologia, 1985, 28: 412- 419.
  • 2曹旭,田浩明.胰岛素抵抗的分子机制研究进展[J].医学新知,2004,14(2):114-116. 被引量:10
  • 3朱禧星,张维仁,何德华,等.自β细胞功能和胰岛素受体活性探讨中、老年糖尿病诊断和治疗[J].中华内分泌代谢杂志,1987,3(4):208-210.
  • 4杨文军,庄严.胰岛素抵抗综合征辨治初探[J].山东中医药大学学报,2002,26(4):275-276. 被引量:32

二级参考文献20

  • 1李建夫,魏玮.继发性磺脲类失效糖尿病人中药处理的观察[J].中医药研究,1995,11(3):24-25. 被引量:4
  • 2Mian shin Tan, Shu ying Chang, Dao ming Chang, et al. Association of resistin gene 3′- untranslated region +62G→A polymorphism with type 2 diabetes and hypertension in a Chinese population. J Clin Endocrinol Metab, 2003, 88(3):1258
  • 3Sano R, Miki T, Suzuki Y, et al. Analysis of the insulin-sensitive phosphodiesterase 3B gene in type 2 diabetes. Diabetes Res Clin Pract, 2001,54(1):79
  • 4Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverse insulin resistance associated with both lipoatrophy and obesity. Nut Med, 2001, 7(8):941
  • 5Stefan N, Stumvoll M. Adiponectin-its role in metabolism and beyond. Horm-Metab-Res, 2002,34(9):469
  • 6Fehmann H C, Peiser C, Bode H P, et al. Leptin: a potent inhibitor of insulin secretion. Peptides, 1997, 18(8):1267
  • 7Miles P D G, Barak Y, He W, et al. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest, 2000, 105(3):287
  • 8Hsueh W A, Law R. The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease. Am J Cardiol, 2002, 92(4A):3J
  • 9Steppan C M, Bailey S T, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature, 2001, 409(6818):307
  • 10Pickup J C, Crook M A. Is type Ⅱ diabetes mellitus a disease of innate immune system Diabetologia, 1998,41(10):1241

共引文献42

同被引文献70

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部